3553 results for «2265»

Filter By

3553 results

Master TR with trusted technology - TriClip

24 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to discover how TriClip technology allows you treating a broad range of tricuspid valve anatomies throughout a step by step live case and to learn on tips and tricks when imaging the tricuspid valve for TTVr.

Master TR with trusted

The Edwards portfolio - Innovation in mitral and tricuspid repair & replacement

24 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to explore the clinical impact of the Edwards portfolio of transcatheter devices for MR and TR treatment and to participate in recorded case demonstrations using the Cardioband tricuspid and PASCAL repair systems.

The Edwards portfolio

Innovations in surgical and transcatheter mitral valve intervention

23 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to hear more about the latest advances in surgical and transcatheter approaches to mitral valve disease and to appreciate the anatomical, clinical and engineering challenges associated with future development.

This session was originally presented during PCR Valves e-Course 2020.

Innovations in surgical and transcatheter mitral valve intervention

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.

Shaping care pathways for severe aortic stenosis patients in a COVID-19 context

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...

Portico FlexNav - Optimise TAVI outcomes from routine to complex cases

Hot lines on Mitral interventions – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.

Hot Lines on mitral interventions

PCR e-Course Hot lines on TAVI – part 1

25 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.

Hotlines on TAVI

PCR e-Course 2020 Clinical cases

25 Jun 2020 – From PCR e-Course 2020

Watch a series of best clinical cases presented at the PCR e-Course 2020:

  • ACS-patient with culprit in a coronary ectasia
  • Coronary stenting in an ectatic artery
  • Challenging PCI after aortic valve-in-valve implantation
  • Cisplatin-induced coronary artery thrombosis presented as ACS
  • MOCA I study: microvascular obstruction measured using dMVR
  • The many faces of in-stent...
PCR e-Course Clinical cases

How to treat complex bifurcation lesions? From bench to being

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to understand the best treatment options for patients presenting with complex bifurcation lesion, to share a benchtop simulation of bifurcation techniques and to learn how to optimise both strategy and technique.

How to treat complex bifurcation lesions

Emerging from the SARS-COV-2 crisis: using immersive team simulation to optimise safety and outcomes

03 Jul 2020 – From PCR e-Course 2020

In this video, Rasha Al-Lamee, UK; Iqbal Malik, UK and David Sparv, Sweden, share information on how you can integrate simulation in your own cathlab to maintain quality and safety without training on real people.

Related content:  Access a collection of valuable resources on how to protect...

Emerging from the SARS-COV-2 crisis: using immersive team simulation to optimise safety and outcomes

Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn and understand how and where to use a Sirolimus DCB in current practice, to see clinical evidences and results for the treatment of Patients with Sirolimus DCB and to see the potential advantages of using the Sirolimus over...

Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel

LAA occlusion vs. novel oral anticoagulation in atrial fibrillation

27 Jun 2020 – From PCR e-Course 2020

Learn which patients may benefit from LAA Occlusion (LAAO) vs. long term anticoagulation, and access the latest data of LAAO vs NOAC from a substantial cohort in a propensity score matched study to find out what impact it might have medium and longer term.

Videos included on...

LAA occlusion vs. novel oral anticoagulation

Treating tricuspid regurgitation with the PASCAL repair system

Watch this roundtable discussion on the treatment of tricuspid regurgitation with the recently approved in Europe PASCAL Repair System.

Treating tricuspid regurgitation with the PASCAL repair system

Crossover results from the RADIANCE-HTN SOLO trial

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.

Videos included on this page: the Hot Line presentation, an...

Latest evidence from the RADIANCE-HTN trial and the path to clinical adoption

How the interventional cardiologist should approach patients with a vasculogenic erectile dysfunction?

Watch this roundtable discussion if you want to learn how cardiologist should approach the patients with erectile dysfunction and to see how to treat a patient with ED with Sirolimus Coated Balloon

How the interventional cardiologist should approach patients with a vasculogenic erectile dysfunction?

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

25 Jun 2020 – From PCR e-Course 2020

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study

TAVI: Full one-year Evolut low-risk randomised results and economic implications

EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications  to understand the potential drivers for TAVI cost-effectives in Europe.

Videos included on this page: the Hot Line presentation and an Investigator Perspective.

Full one-year Evolut low-risk randomised results and economic implications
Didn’t find what you were looking for?